FDC Limited Share Price

FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.As of 25 May 2026, FDC Limited share price is ₹369.35. The stock opened at ₹375.40, compared to its previous close of ₹373.25. During today's trading session, FDC Limited share price moved in the range of ₹363.55 to ₹375.40, with an average price of ₹369.48 for the day. Looking at its last 52-week, the stock has touched a low of ₹363.55 and a high of ₹375.40. On the performance front, FDC Limited share price has declined by 11.45% over the last six months and is down 20.79% on a year-on-year basis.

The market capitalization of FDC Limited is ₹6,079 Crs, with a P/E ratio of 28.1 and a dividend yield of 1.34%.